Here, we analyzed the effects of deficiency of FK506-binding protein 10 (FKBP10), a potential IPF drug target, on primary human lung fibroblast (phLF) adhesion and migration. The gene discussed is FKBP10; the disease is idiopathic pulmonary fibrosis.